Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 4336-4341, August 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simard, J.
Right arrow Articles by Labrie, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simard, J.
Right arrow Articles by Labrie, F.

Stimulation of Apolipoprotein D Secretion by Steroids Coincides with Inhibition of Cell Proliferation in Human LNCaP Prostate Cancer Cells1

Jacques Simard2, Raymonde Veilleux, Yvan de Launoit, Darrow E. Haagensen and Fernand Labrie

Medical Research Council Group in Molecular Endocrinology, CHUL Research Center and Laval University, Quebec G1V 4G2, Canada [J. S., R. V., Y. d. L., F. L.], and Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110 [D. E. H.]

Although steroid hormones are known to play a predominant role in the regulation of cell growth in hormone-sensitive cancers, their mechanisms of action, especially their interaction with growth factors and/or growth inhibitors, is poorly understood. We have recently observed that the effects of androgens and estrogens on the expression of the major protein found in human breast gross cystic disease fluid, protein-24, are opposite to their respective action on cell proliferation in human breast cancer cell lines. Somewhat surprisingly, the recent elucidation of the amino acid sequence of this progesterone binding protein reveals that this tumor marker is apolipoprotein D (apo D), a member of a superfamily of lipophilic ligand carrier proteins. The present study was designed to determine whether apo D is secreted by human prostate cancer cells and could thus be a new marker of steroid action in these cancer cells, and whether the sex steroid-induced stimulation of apo D secretion coincides with inhibition of cell proliferation. We took advantage of the biphasic pattern of the effect of steroids on the proliferation of the human prostate cancer LNCaP cell line, which offers the opportunity to discriminate between positive and negative steroid receptor-regulated cell growth processes. A 10-day exposure to low concentrations of dihydrotestosterone and testosterone caused a potent stimulation of LNCaP cell proliferation, whereas incubation with higher concentrations of these androgens led to a progressive decrease in cell proliferation towards basal levels. The biphasic action of androgens was also observed on apo D secretion, the effects on apo D secretion being inversely related to their action on LNCaP cell proliferation. Similar opposite biphasic effects were also observed with 9 other steroids, thus indicating that the stimulation of secretion of this new biochemical marker coincides with inhibition of cell proliferation in LNCaP human prostatic cancer cells.

1 Financial support was from Pharmacia Canada and Endorecherche. J. S. is holder of a Scholarship from the Medical Research Council of Canada. Y. d. L. is holder of a postdoctoral fellowship from the Medical Research Council of Canada.

2 To whom requests for reprints should be addressed, at MRC Group in Molecular Endocrinology, CHUL Research Center, 2705 Laurier Boulevard, Quebec G1V 4G2, Canada.

Received 4/24/91. Accepted 6/ 4/91.




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
S. B. Hunter, V. Varma, B. Shehata, J.D.L. Nolen, C. Cohen, J. J. Olson, and C.-Y. Ou
Apolipoprotein D Expression in Primary Brain Tumors: Analysis by Quantitative RT-PCR in Formalin-fixed, Paraffin-embedded Tissue
J. Histochem. Cytochem., August 1, 2005; 53(8): 963 - 969.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. del Valle, A. Navarro, A. Astudillo, and J. Tolivia
Apolipoprotein D Expression in Human Brain Reactive Astrocytes
J. Histochem. Cytochem., October 1, 2003; 51(10): 1285 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. J. Long, D. N. Grigoryev, I. P. Nnane, Y. Liu, Y.-Z. Ling, and A. M. Brodie
Antiandrogenic Effects of Novel Androgen Synthesis Inhibitors on Hormone-dependent Prostate Cancer
Cancer Res., December 1, 2000; 60(23): 6630 - 6640.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
C. Lopez-Otin and E. P. Diamandis
Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev., August 1, 1998; 19(4): 365 - 396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.